As a medical treatment for otospongiosis-otosclerosis, sodium fluoride
influences the underlying bony changes in the labyrinth so as to arre
st or prevent the onset of hearing loss. Sodium fluoride is an enzyme
inhibitor and reduces osteoclastic bone resorption and, if the dosage
is more than 60 mg a day, may rebuild pseudohaversian bone.